# Valentina Guarneri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/valentina-guarneri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,609 |
| Field | Breast Cancer Treatment Studies |
| h-index | 68 |
| i10-index | 238 |
| Last Known Institution | University of Padua |
| OpenAlex ID | https://openalex.org/A5034632931 |
| ORCID iD | https://orcid.org/0000-0002-2375-8397 |
| Works | 794 |

## Researcher papers

- [Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up](https://scholariq.org/papers/early-breast-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment-and/)
- [Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer](https://scholariq.org/papers/primary-results-from-impassion131-a-double-blind-placebo-controlled-randomised/)
- [Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study](https://scholariq.org/papers/prognostic-value-of-tumor-infiltrating-lymphocytes-on-residual-disease-after/)
- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast/)
- [Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials](https://scholariq.org/papers/prognostic-and-predictive-value-of-tumor-infiltrating-lymphocytes-in-two-phase/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [University of Padua](https://scholariq.org/institutions/university-of-padua/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.